|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002871,
umls-concept:C0014822,
umls-concept:C0034656,
umls-concept:C0086418,
umls-concept:C0087111,
umls-concept:C0280100,
umls-concept:C0332281,
umls-concept:C0681867,
umls-concept:C1514873,
umls-concept:C1708528,
umls-concept:C1879316
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1998-7-23
|
|
pubmed:abstractText |
Anemia is a common side effect of anticancer chemotherapy. Blood transfusion, previously the only available treatment for chemotherapy-induced anemia, may result in some clinical or subclinical adverse effects in the recipients. Recombinant human erythropoietin (rhEPO) provides a new treatment modality for chemotherapy-induced anemia.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AmadoriDD,
pubmed-author:ArmandJ PJP,
pubmed-author:GamucciTT,
pubmed-author:HerrmannRR,
pubmed-author:MonfardiniSS,
pubmed-author:NeryRR,
pubmed-author:Netter-PinonJJ,
pubmed-author:NowrousianM RMR,
pubmed-author:OberhoffCC,
pubmed-author:PetryK UKU,
pubmed-author:RebmannUU,
pubmed-author:Tubiana-MathieuNN,
pubmed-author:VoigtmannRR,
pubmed-author:ZwierzinaHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
255-60
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9602258-Adult,
pubmed-meshheading:9602258-Aged,
pubmed-meshheading:9602258-Anemia,
pubmed-meshheading:9602258-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9602258-Blood Transfusion,
pubmed-meshheading:9602258-Carboplatin,
pubmed-meshheading:9602258-Cisplatin,
pubmed-meshheading:9602258-Erythrocyte Count,
pubmed-meshheading:9602258-Erythropoietin,
pubmed-meshheading:9602258-Female,
pubmed-meshheading:9602258-Hemoglobins,
pubmed-meshheading:9602258-Humans,
pubmed-meshheading:9602258-Injections, Subcutaneous,
pubmed-meshheading:9602258-Male,
pubmed-meshheading:9602258-Middle Aged,
pubmed-meshheading:9602258-Neoplasms,
pubmed-meshheading:9602258-Prognosis,
pubmed-meshheading:9602258-Recombinant Proteins,
pubmed-meshheading:9602258-Statistics, Nonparametric,
pubmed-meshheading:9602258-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study.
|
|
pubmed:affiliation |
Center for Gynecology and Obstetrics, University Hospital, Essen, Germany. carsten.oberhoff@uni-essen.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
